UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4

Genome medicine, 2019-12, Vol.11 (1), p.87-87, Article 87

2019

Volltextzugriff (PDF)

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

Cancer Immunology, Immunotherapy, 2011-07, Vol.60 (7), p.953-963

2011

Volltextzugriff (PDF)

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer

Cancer Immunology, Immunotherapy, 2016-12, Vol.65 (12), p.1451-1463

2016

Volltextzugriff (PDF)

Cancer immunotherapy: broadening the scope of targetable tumours

Open biology, 2018-06, Vol.8 (6)

2018

Volltextzugriff (PDF)

Adoptive cell therapy: a highly successful individualized therapy for melanoma with great potential for other malignancies

Current opinion in immunology, 2016-04, Vol.39, p.90-95

Verdegaal, Els ME

2016

Volltextzugriff (PDF)

Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma

Pigment cell and melanoma research, 2013-07, Vol.26 (4), p.542-554

2013

Volltextzugriff (PDF)

The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells

International journal of molecular sciences, 2021-12, Vol.23 (1), p.137

2021

Volltextzugriff (PDF)

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma

Cancer Immunology, Immunotherapy, 2017-07, Vol.66 (7), p.913-926

2017

Volltextzugriff (PDF)

Targeting of the Cancer-Associated Fibroblast-T-Cell Axis in Solid Malignancies

Journal of clinical medicine, 2019-11, Vol.8 (11), p.1989

2019

Volltextzugriff (PDF)

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines

Chembiochem : a European journal of chemical biology, 2021-04, Vol.22 (7), p.1215-1222

2021

Volltextzugriff (PDF)

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer

Frontiers in immunology, 2023-03, Vol.14, p.1121973-1121973

2023

Volltextzugriff (PDF)

Near-genomewide RNAi screening for regulators of BRAFV600E-induced senescence identifies RASEF, a gene epigenetically silenced in melanoma

Pigment cell and melanoma research, 2014-07, Vol.27 (4), p.640-652

2014

Volltextzugriff (PDF)

Neoantigen landscape dynamics during human melanoma-T cell interactions

Nature (London), 2016-08, Vol.536 (7614), p.91-95

2016

Volltextzugriff (PDF)

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy

Frontiers in immunology, 2017-09, Vol.8, p.1113-1113

2017

Volltextzugriff (PDF)

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e005887

2023

Volltextzugriff (PDF)

Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer

Journal for immunotherapy of cancer, 2023-11, Vol.11 (11), p.e007697

2023

Volltextzugriff (PDF)

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

Nature medicine, 2015-01, Vol.21 (1), p.81-85

2015

Volltextzugriff (PDF)

Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial

BMJ open, 2020-11, Vol.10 (11), p.e044036

2020

Volltextzugriff (PDF)

Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma

Journal for immunotherapy of cancer, 2024-06, Vol.12 (6), p.e009215

2024

Volltextzugriff (PDF)

Identification of non-mutated neoantigens presented by TAP-deficient tumors

The Journal of experimental medicine, 2018-09, Vol.215 (9), p.2325-2337

2018

Volltextzugriff (PDF)

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

Cancer immunology research, 2019-01, Vol.7 (1), p.6-11

2019

Volltextzugriff (PDF)

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S

Journal for immunotherapy of cancer, 2022-03, Vol.10 (3), p.e003591

2022

Volltextzugriff (PDF)

Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e001607

2020

Volltextzugriff (PDF)

Neoantigen targetability in progressive advanced melanoma

Clinical cancer research, 2023-10, Vol.29 (20), p.4278-4288

2023

Volltextzugriff (PDF)

Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β

Cytokine (Philadelphia, Pa.), 2013-02, Vol.61 (2), p.645-655

2013

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer

Cancer immunotherapy: broadening the scope of targetable tumours

Adoptive cell therapy: a highly successful individualized therapy for melanoma with great potential for other malignancies

Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma

The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma

Targeting of the Cancer-Associated Fibroblast-T-Cell Axis in Solid Malignancies

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer

Near-genomewide RNAi screening for regulators of BRAFV600E-induced senescence identifies RASEF, a gene epigenetically silenced in melanoma

Neoantigen landscape dynamics during human melanoma-T cell interactions

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden

Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial

Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma

Identification of non-mutated neoantigens presented by TAP-deficient tumors

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S

Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer

Neoantigen targetability in progressive advanced melanoma

Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β

Suchergebnisse filtern